Literature DB >> 20938722

Myocardial fibrosis and TGFB expression in hyperhomocysteinemic rats.

Lamia Raaf1, Christophe Noll, Mohamed El Hadi Cherifi, Jane-Lise Samuel, Claude Delcayre, Jean-Maurice Delabar, Yasmina Benazzoug, Nathalie Janel.   

Abstract

Hyperhomocysteinemia, characterized by an elevated plasma homocysteine concentration, leads to several clinical manifestations and particularly cardiovascular diseases. Experimental models of hyperhomocysteinemia revealed several tissue injuries including heart fibrosis and ventricular hypertrophy. In order to analyze the molecular mechanisms link to these morphological alterations, a mild hyperhomocysteinemia was induced in rats via a chronic methionine administration. Effects of methionine administration were examined by histological analysis with Sirius red staining, histomorphometric analysis, zymography, and immunoblotting. Hyperhomocysteinemia due to methionine administration produces an interstitial myocardial fibrosis and a ventricular cardiomyocyte hypertrophy, which were associated with increased expression of transforming growth factor-beta1 (TGFβ1), tissue inhibitors of metalloproteinase (TIMP) 2, and JNK activation. However, the matrix metalloproteinase 2 activity was decreased in the hearts of hyperhomocysteinemic rats. Moreover, the TIMP1 protein expression was decreased, and the TIMP1-MMP1 balance was shifted. Remodeling in cardiac tissue observed in rat model of mild hyperhomocysteinemia is associated with a dysregulation in extracellular matrix degradation which results, at least in part, from enhancement of TGFβ1 level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938722     DOI: 10.1007/s11010-010-0612-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways.

Authors:  Gabriella Doronzo; Isabella Russo; Luigi Mattiello; Mariella Trovati; Giovanni Anfossi
Journal:  Thromb Haemost       Date:  2005-12       Impact factor: 5.249

2.  High glucose and homocysteine synergistically affect the metalloproteinases-tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts.

Authors:  A Solini; E Santini; M Nannipieri; E Ferrannini
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

3.  Influence of homocysteine on matrix metalloproteinase-2: activation and activity.

Authors:  A Bescond; T Augier; C Chareyre; D Garçon; W Hornebeck; P Charpiot
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

4.  Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver.

Authors:  Karine Robert; Johnny Nehmé; Emmanuel Bourdon; Gérard Pivert; Bertrand Friguet; Claude Delcayre; Jean-Maurice Delabar; Nathalie Janel
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

5.  Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice.

Authors:  Esther E J M Creemers; Jeniffer N Davis; Andrea M Parkhurst; Peter Leenders; Kathryn B Dowdy; Elizabeth Hapke; Anne M Hauet; Patricia G Escobar; Jack P M Cleutjens; Jos F M Smits; Mat J A P Daemen; Michael R Zile; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09-26       Impact factor: 4.733

6.  Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells.

Authors:  A Majors; L A Ehrhart; E H Pezacka
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

7.  Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase.

Authors:  U Seeland; C Haeuseler; R Hinrichs; S Rosenkranz; T Pfitzner; K Scharffetter-Kochanek; M Böhm
Journal:  Eur J Clin Invest       Date:  2002-05       Impact factor: 4.686

8.  Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase.

Authors:  Philipp Stawowy; Christian Margeta; Heike Kallisch; Nabil G Seidah; Michel Chrétien; Eckart Fleck; Kristof Graf
Journal:  Cardiovasc Res       Date:  2004-07-01       Impact factor: 10.787

9.  Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.

Authors:  Yuansheng Zhai; Xiuren Gao; Qiaomei Wu; Longyun Peng; Jun Lin; Zhiyi Zuo
Journal:  Eur J Pharmacol       Date:  2008-03-15       Impact factor: 4.432

10.  Mice lacking cystathionine beta synthase have lung fibrosis and air space enlargement.

Authors:  Julien Hamelet; Nicole Maurin; Romain Fulchiron; Jean-Maurice Delabar; Nathalie Janel
Journal:  Exp Mol Pathol       Date:  2007-05-06       Impact factor: 3.362

View more
  11 in total

1.  Mild hyperhomocysteinemia reduces the activity and immunocontent, but does not alter the gene expression, of catalytic α subunits of cerebral Na+,K+-ATPase.

Authors:  Emilene B S Scherer; Samanta O Loureiro; Fernanda C Vuaden; Felipe Schmitz; Janaína Kolling; Cassiana Siebert; Luiz Eduardo B Savio; Bruna M Schweinberger; Maurício R Bogo; Carla D Bonan; Angela T S Wyse
Journal:  Mol Cell Biochem       Date:  2013-03-07       Impact factor: 3.396

2.  Selective homocysteine-lowering gene transfer attenuates pressure overload-induced cardiomyopathy via reduced oxidative stress.

Authors:  Ilayaraja Muthuramu; Neha Singh; Ruhul Amin; Elena Nefyodova; Mirjam Debasse; Isa Van Horenbeeck; Frank Jacobs; Bart De Geest
Journal:  J Mol Med (Berl)       Date:  2015-04-11       Impact factor: 4.599

3.  Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population.

Authors:  Yvonne Lee Yin Leng; Yuling Zhou; Honghong Ke; Herbert Jelinek; Joel McCabe; Hassan Assareh; Craig S McLachlan
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

4.  Intermedin1-53 Protects Against Myocardial Fibrosis by Inhibiting Endoplasmic Reticulum Stress and Inflammation Induced by Homocysteine in Apolipoprotein E-Deficient Mice.

Authors:  Jin-Sheng Zhang; Yue-Long Hou; Wei-Wei Lu; Xian-Qiang Ni; Fan Lin; Yan-Rong Yu; Chao-Shu Tang; Yong-Fen Qi
Journal:  J Atheroscler Thromb       Date:  2016-04-06       Impact factor: 4.928

5.  Hydrogen sulfide alleviates myocardial fibrosis in mice with alcoholic cardiomyopathy by downregulating autophagy.

Authors:  Biao Liang; Ting Xiao; Junrong Long; Maojun Liu; Zining Li; Shengquan Liu; Jun Yang
Journal:  Int J Mol Med       Date:  2017-10-16       Impact factor: 4.101

6.  Hydrogen Sulfide Ameliorates Homocysteine-Induced Cardiac Remodeling and Dysfunction.

Authors:  Sumit Kar; Hamid R Shahshahan; Tyler N Kambis; Santosh K Yadav; Zhen Li; David J Lefer; Paras K Mishra
Journal:  Front Physiol       Date:  2019-05-24       Impact factor: 4.566

7.  The association between levels of serum homocysteine and chronic heart failure: A protocol for systematic review and meta-analysis.

Authors:  Xi Wang; Fu Wang; Zhiquan Feng; Jun Cai; Jianbin Liu
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

8.  Selective homocysteine lowering gene transfer improves infarct healing, attenuates remodelling, and enhances diastolic function after myocardial infarction in mice.

Authors:  Ilayaraja Muthuramu; Frank Jacobs; Neha Singh; Stephanie C Gordts; Bart De Geest
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

Review 9.  Defective homocysteine metabolism: potential implications for skeletal muscle malfunction.

Authors:  Sudhakar Veeranki; Suresh C Tyagi
Journal:  Int J Mol Sci       Date:  2013-07-18       Impact factor: 5.923

10.  Weighted gene co‑expression network analysis in identification of key genes and networks for ischemic‑reperfusion remodeling myocardium.

Authors:  Nan Guo; Nan Zhang; Liqiu Yan; Zheng Lian; Jiawang Wang; Fengfeng Lv; Yunfei Wang; Xufen Cao
Journal:  Mol Med Rep       Date:  2018-06-14       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.